首页> 美国卫生研究院文献>Acta Crystallographica Section F: Structural Biology and Crystallization Communications >Structure determination of LpxA from the lipopolysaccharide-synthesis pathway of Acinetobacter baumannii
【2h】

Structure determination of LpxA from the lipopolysaccharide-synthesis pathway of Acinetobacter baumannii

机译:从鲍曼不动杆菌的脂多糖合成途径确定LpxA的结构

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Acinetobacter baumannii is a Gram-negative pathogenic bacterium which is resistant to most currently available antibiotics and that poses a significant health threat to hospital patients. LpxA is a key enzyme in the biosynthetic pathway of the lipopolysaccharides that are components of the bacterial outer membrane. It is a potential target for antibacterial agents that might be used to fight A. baumannii infections. This paper describes the structure determination of the apo form of LpxA in space groups P212121 and P63. These crystal forms contained three and one protein molecules in the asymmetric unit and diffracted to 1.8 and 1.4 Å resolution, respectively. A comparison of the conformations of the independent protein monomers within and between the two crystal asymmetric units revealed very little structural variation across this set of structures. In the P63 crystal form the enzymatic site is exposed and is available for the introduction of small molecules of the type used in fragment-based drug discovery and structure-based lead optimization.
机译:鲍曼不动杆菌是革兰氏阴性致病菌,它对目前大多数可用的抗生素具有抗性,并且对医院患者的健康构成重大威胁。 LpxA是脂多糖的生物合成途径中的关键酶,脂多糖是细菌外膜的组成部分。它是可能用于抵抗鲍曼不动杆菌感染的抗菌剂的潜在目标。本文描述了空间群P212121和P63中LpxA载脂蛋白形式的结构测定。这些晶体形式在不对称单元中包含三个和一个蛋白质分子,分别衍射至1.8和1.4Å分辨率。在两个晶体不对称单元之内和之间的独立蛋白质单体构象的比较表明,在这组结构中几乎没有结构变化。在P63晶体形式中,酶位点被暴露出来,可用于引入基于片段的药物发现和基于结构的前导最优化的小分子类型。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号